Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02744027 · ClinicalTrials.gov registry record · NA
Imaging of Lymphatic Anomalies
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02744027 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 10 participants.
The verdict
NCT02744027, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR Lymphangiogram (DCMRL) may be useful in investigating pathological changes in the lymphatic system.
Interventions
- OTHER Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL)
- OTHER Heavy Weighted T2 Imaging (T2W)
- OTHER Lymph Node Access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02744027
The ClinicalTrials.gov registry entry for NCT02744027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL) is the first listed.
NCT02744027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02744027 about?
NCT02744027 is a clinical study titled "Imaging of Lymphatic Anomalies". Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR Lymphangiogram (DCMRL) ...
What is the current status of trial NCT02744027?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-04. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02744027?
The interventions under investigation include: Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL) (OTHER), Heavy Weighted T2 Imaging (T2W) (OTHER), Lymph Node Access (OTHER).
Who is sponsoring clinical trial NCT02744027?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.